Examining the Impact of Aerobic and Core Exercises on Primary Dysmenorrhea in High School Females
Dysmenorrhea
Investigation of the Effects of Aerobic and Core Stabilization Exercises on Primary Dysmenorrhea in High School Female Students
1 other identifier
interventional
50
1 country
1
Brief Summary
Dysmenorrhea, derived from ancient Greek, translates to 'difficult monthly flow' and refers to painful cramps during menstruation, a common cause of pelvic pain. The pain, often in the lower abdomen, results from uterine pressure exceeding 60 mmHg. Symptoms include suprapubic pain, radiating discomfort, nausea, diarrhea, and headache, impacting quality of life. Etiology involves factors like age at menarche, heavy flow, lifestyle, and medical conditions. Dysmenorrhea is categorized as primary (without underlying pathology) or secondary (due to conditions like endometriosis). Its prevalence is high in adolescence, affecting daily life, school, and health. Research aims to assess how aerobic and core exercises influence pain and quality of life in adolescent females (14-18 years). Participants are randomly assigned to study and control groups, exploring the potential benefits for health, well-being, and academic performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 22, 2024
July 1, 2024
3 months
February 26, 2024
July 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Visual Analog Scale
VAS is a common tool for assessing subjective experiences like pain or mood intensity. It consists of a 10-centimeter line with clear endpoints representing extreme sensations. Participants mark a point on the line corresponding to their perception, such as "No Pain" to "Worst Pain Imaginable." The distance from "No Pain" provides a quantitative measure. Easy to administer and adaptable, VAS is widely used in clinical and research settings for various subjective states beyond pain, requiring no specialized training. "In this scale, '0' corresponds to the best, and '10' to the worst
baseline and 12 weeks
Functional and Emotional functional and emotional measure of dysmenorrhea (FEMD)
"FEMD" stands for Functional and Emotional Measure of Dysmenorrhea. Dysmenorrhea refers to painful menstruation, commonly known as menstrual cramps. The FEMD is a tool or scale used to assess both the functional and emotional impacts of dysmenorrhea on individuals. The functional aspect of the FEMD typically evaluates the severity of physical symptoms associated with dysmenorrhea, such as the intensity of pain, its duration, any associated symptoms like nausea or vomiting, and how these symptoms affect daily activities or functioning. The scale consists of 14 items and 2 subscales. Each item is scored on a scale from 1 to 5: (1) Not at all like my condition, (2) Not much like my condition, (3) Somewhat like and somewhat unlike my condition, (4) Much like my condition, (5) Very much like my condition. There are no reverse items. As scores increase on this scale, individuals' levels of functional and emotional impact from dysmenorrhea also increase."
baseline and 12 weeks
Secondary Outcomes (4)
SF-36 Short Form 36 Health Survey
baseline and 12 weeks
A dysmenorrhea monitoring form
baseline and 12 weeks
Dysmenorrhea Impact Scale short form
baseline and 12 weeks
Menstrual Symptom Questionnaire
baseline and 12 weeks
Study Arms (2)
Aerobic Exercise Group
ACTIVE COMPARATORAerobic Exercise Group For 3 months, participants will engage in a total of 150 minutes of exercise per week, either 30 minutes for 5 days a week or 50 minutes for 3 days a week.
Core Stabilization Exercise Group
ACTIVE COMPARATORCore Stabilization Exercise Group for 3 months, 2 sets of exercises, each comprising 10 repetitions per set.
Interventions
Aerobic and Core Stabilization Exercise Intervention
Eligibility Criteria
You may qualify if:
- Be nulliparous (have not given birth) and be between the ages of 14-18.
- Volunteer to participate.
- Have no active sexual life.
- Have a regular menstrual cycle.
- Report a pain intensity of 5 or above on the Visual Analog Scale (VAS).
- Have a Body Mass Index (BMI) between 19 and 24.9.
- Not have polycystic ovary syndrome or undergone any surgical operation related to female diseases.
- Not engage in regular exercise.
- Not have any chronic, systemic, neurological, or endocrinological diseases.
You may not qualify if:
- Participate in tele-rehabilitation and exercise diary for less than 3 days.
- Use an intrauterine device.
- Have taken pharmacological supplements in the last 3 months or during the study tracking period (due to reasons such as flu, COVID, etc.).
- Have any physical impediment restricting physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Bilgi University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aycan Cakmak Reyhan, PhD
Istanbul Bilgi University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 26, 2024
First Posted
May 1, 2024
Study Start
March 1, 2024
Primary Completion
May 30, 2024
Study Completion
June 30, 2024
Last Updated
July 22, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share